Nifty
Sensex
:
:
24586.70
80664.86
84.55 (0.35%)
145.52 (0.18%)

Pharmaceuticals & Drugs - API

Rating :
N/A

BSE: 540222 | NSE: LAURUSLABS

477.15
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  456.80
  •  481.45
  •  453.75
  •  454.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  11785336
  •  55586.44
  •  484.30
  •  328.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 25,134.11
  • 158.41
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 27,499.51
  • 0.17%
  • 6.11

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 27.18%
  • 7.82%
  • 22.68%
  • FII
  • DII
  • Others
  • 25.67%
  • 13.12%
  • 3.53%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.28
  • 12.23
  • 0.71

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.83
  • 6.61
  • -11.38

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.35
  • -8.19
  • -41.41

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.97
  • 31.71
  • 33.48

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.56
  • 6.52
  • 7.05

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.80
  • 18.02
  • 19.88

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
1,439.67
1,380.90
4.26%
1,194.92
1,544.82
-22.65%
1,224.45
1,575.89
-22.30%
1,181.79
1,538.94
-23.21%
Expenses
1,198.18
1,095.36
9.39%
1,013.50
1,141.25
-11.19%
1,036.58
1,126.98
-8.02%
1,015.07
1,084.77
-6.43%
EBITDA
241.49
285.54
-15.43%
181.42
403.57
-55.05%
187.87
448.91
-58.15%
166.72
454.17
-63.29%
EBIDTM
16.77%
20.68%
15.18%
26.12%
15.34%
28.49%
14.11%
29.51%
Other Income
18.53
1.71
983.63%
2.43
1.43
69.93%
1.78
1.11
60.36%
3.60
1.75
105.71%
Interest
50.50
53.10
-4.90%
50.82
42.71
18.99%
42.39
40.11
5.68%
39.19
29.25
33.98%
Depreciation
102.25
87.01
17.52%
98.41
84.44
16.54%
93.37
81.84
14.09%
90.55
70.79
27.91%
PBT
107.27
147.14
-27.10%
34.62
277.85
-87.54%
53.89
328.07
-83.57%
40.58
355.88
-88.60%
Tax
31.95
39.90
-19.92%
9.45
74.79
-87.36%
14.57
94.27
-84.54%
12.18
103.34
-88.21%
PAT
75.32
107.24
-29.77%
25.17
203.06
-87.60%
39.32
233.80
-83.18%
28.40
252.54
-88.75%
PATM
5.23%
7.77%
2.11%
13.14%
3.21%
14.84%
2.40%
16.41%
EPS
1.40
1.91
-26.70%
0.43
3.77
-88.59%
0.69
4.33
-84.06%
0.46
4.68
-90.17%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
-
5,040.83
6,040.55
4,935.57
4,813.51
2,831.72
2,291.92
2,056.17
1,904.65
1,777.58
1,326.59
Net Sales Growth
-
-16.55%
22.39%
2.54%
69.99%
23.55%
11.47%
7.96%
7.15%
34.00%
 
Cost Of Goods Sold
-
2,374.35
2,729.67
2,133.89
2,107.62
1,382.88
1,224.80
1,056.02
989.29
1,000.15
821.27
Gross Profit
-
2,666.48
3,310.88
2,801.68
2,705.89
1,448.84
1,067.12
1,000.15
915.36
777.43
505.32
GP Margin
-
52.90%
54.81%
56.77%
56.21%
51.16%
46.56%
48.64%
48.06%
43.74%
38.09%
Total Expenditure
-
4,263.33
4,448.36
3,513.14
3,262.83
2,267.17
1,935.93
1,642.85
1,497.01
1,415.38
1,131.46
Power & Fuel Cost
-
338.15
324.10
204.47
157.75
136.77
109.37
94.21
66.27
57.95
49.86
% Of Sales
-
6.71%
5.37%
4.14%
3.28%
4.83%
4.77%
4.58%
3.48%
3.26%
3.76%
Employee Cost
-
614.85
557.43
469.55
397.04
320.77
276.33
238.14
204.73
175.46
131.38
% Of Sales
-
12.20%
9.23%
9.51%
8.25%
11.33%
12.06%
11.58%
10.75%
9.87%
9.90%
Manufacturing Exp.
-
611.80
522.90
441.18
364.78
239.50
178.96
150.78
139.47
106.97
80.61
% Of Sales
-
12.14%
8.66%
8.94%
7.58%
8.46%
7.81%
7.33%
7.32%
6.02%
6.08%
General & Admin Exp.
-
157.89
151.15
146.49
133.28
114.23
97.48
73.17
65.42
49.09
28.39
% Of Sales
-
3.13%
2.50%
2.97%
2.77%
4.03%
4.25%
3.56%
3.43%
2.76%
2.14%
Selling & Distn. Exp.
-
134.49
116.14
101.98
91.65
61.53
31.96
24.09
22.65
16.49
12.46
% Of Sales
-
2.67%
1.92%
2.07%
1.90%
2.17%
1.39%
1.17%
1.19%
0.93%
0.94%
Miscellaneous Exp.
-
31.80
46.97
15.58
10.71
11.49
17.03
6.44
9.18
9.27
12.46
% Of Sales
-
0.63%
0.78%
0.32%
0.22%
0.41%
0.74%
0.31%
0.48%
0.52%
0.56%
EBITDA
-
777.50
1,592.19
1,422.43
1,550.68
564.55
355.99
413.32
407.64
362.20
195.13
EBITDA Margin
-
15.42%
26.36%
28.82%
32.22%
19.94%
15.53%
20.10%
21.40%
20.38%
14.71%
Other Income
-
26.34
6.00
15.30
23.66
5.92
16.15
29.19
33.44
4.36
34.07
Interest
-
182.90
165.17
102.39
68.16
89.59
88.19
79.64
99.90
111.11
101.11
Depreciation
-
384.58
324.08
251.49
205.07
187.27
164.19
125.45
105.98
86.41
61.53
PBT
-
236.36
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
169.04
66.57
Tax
-
68.15
312.30
251.42
317.29
38.34
25.99
69.81
43.86
34.90
-1.55
Tax Rate
-
28.83%
28.16%
23.20%
24.39%
13.06%
21.70%
29.40%
18.65%
20.65%
-2.33%
PAT
-
166.49
793.37
827.72
983.58
255.27
93.76
167.61
191.33
134.14
68.12
PAT before Minority Interest
-
168.21
796.64
832.43
983.82
255.27
93.76
167.61
191.33
134.14
68.12
Minority Interest
-
-1.72
-3.27
-4.71
-0.24
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
3.30%
13.13%
16.77%
20.43%
9.01%
4.09%
8.15%
10.05%
7.55%
5.13%
PAT Growth
-
-79.01%
-4.15%
-15.85%
285.31%
172.26%
-44.06%
-12.40%
42.63%
96.92%
 
EPS
-
3.09
14.71
15.35
18.24
4.73
1.74
3.11
3.55
2.49
1.26

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
4,110.95
4,037.53
3,351.19
2,597.55
1,769.77
1,558.41
1,482.64
1,330.45
856.80
722.10
Share Capital
107.79
107.73
107.47
107.32
106.91
106.44
106.03
105.76
82.38
82.13
Total Reserves
3,981.69
3,917.72
3,234.55
2,485.31
1,658.23
1,446.60
1,370.75
1,218.84
771.47
637.03
Non-Current Liabilities
1,159.18
1,179.48
927.98
692.84
214.24
295.49
174.30
132.34
428.11
363.73
Secured Loans
798.23
761.42
596.34
429.16
165.02
258.71
141.66
124.56
353.61
303.68
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
106.13
0.00
Long Term Provisions
93.47
81.47
72.67
63.19
45.85
30.05
20.84
14.59
6.77
5.13
Current Liabilities
3,112.28
2,432.26
2,681.01
2,457.15
1,692.38
1,423.90
1,306.89
1,120.75
883.75
802.49
Trade Payables
1,051.24
710.65
876.37
1,178.69
615.63
488.31
312.33
263.10
247.61
230.81
Other Current Liabilities
610.73
640.75
839.73
367.25
261.47
244.50
231.26
199.11
141.05
133.34
Short Term Borrowings
1,389.29
995.77
910.72
886.12
790.51
684.21
758.52
644.17
481.42
431.63
Short Term Provisions
61.02
85.09
54.19
25.09
24.77
6.89
4.78
14.37
13.66
6.70
Total Liabilities
8,387.03
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.83
2,583.54
2,168.66
1,888.32
Net Block
3,890.01
3,408.62
2,652.47
2,170.62
1,726.34
1,629.07
1,480.80
1,229.93
1,021.03
801.01
Gross Block
5,652.20
4,794.82
3,750.20
3,027.97
2,387.71
2,105.42
1,793.75
1,418.58
1,106.33
986.17
Accumulated Depreciation
1,762.19
1,386.20
1,097.73
857.35
661.37
476.35
312.95
188.65
85.30
185.16
Non Current Assets
4,552.06
4,198.72
3,623.43
2,675.83
1,864.33
1,814.84
1,716.23
1,443.71
1,165.92
1,024.41
Capital Work in Progress
422.84
550.78
813.22
362.17
67.18
109.63
163.18
143.26
69.60
109.67
Non Current Investment
123.98
49.90
30.81
3.41
3.41
3.40
3.40
3.40
7.04
7.45
Long Term Loans & Adv.
83.50
160.58
84.11
108.52
40.80
25.58
29.36
25.95
29.22
93.94
Other Non Current Assets
31.73
28.84
42.82
31.11
26.60
47.16
39.50
41.17
39.03
12.34
Current Assets
3,834.97
3,461.68
3,344.61
3,074.86
1,812.06
1,462.96
1,247.59
1,139.82
1,002.73
862.27
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,845.41
1,684.81
1,760.30
1,575.45
905.22
681.94
584.78
509.05
487.09
475.50
Sundry Debtors
1,662.92
1,580.44
1,354.18
1,306.06
791.42
709.94
570.59
567.61
444.86
285.07
Cash & Bank
141.65
48.46
75.94
48.46
1.74
3.02
3.06
4.09
28.77
58.88
Other Current Assets
184.99
39.07
19.71
56.50
113.68
68.06
89.16
59.08
42.00
42.82
Short Term Loans & Adv.
147.16
108.90
134.48
88.39
61.91
35.22
58.63
25.01
23.86
22.75
Net Current Assets
722.69
1,029.42
663.60
617.71
119.68
39.05
-59.30
19.07
118.98
59.78
Total Assets
8,387.03
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.82
2,583.53
2,168.65
1,888.32

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
665.69
993.90
911.10
733.00
347.42
297.66
342.49
331.99
181.97
-64.71
PBT
236.36
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
169.04
66.57
Adjustment
562.92
485.71
351.13
254.45
293.21
247.69
216.47
199.38
200.57
136.26
Changes in Working Capital
-29.02
-315.26
-341.61
-594.06
-199.76
-44.46
-49.48
-52.45
-154.37
-250.72
Cash after chg. in Working capital
770.26
1,279.39
1,093.37
961.50
387.06
322.99
404.41
382.12
215.23
-47.89
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-104.57
-285.49
-182.27
-228.50
-39.64
-25.32
-61.91
-50.13
-33.26
-16.82
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-822.42
-996.06
-914.34
-940.99
-221.13
-252.88
-384.15
-288.67
-312.20
-396.95
Net Fixed Assets
-288.19
-567.41
-1,025.56
-572.84
-236.25
-254.84
-394.43
-354.15
-76.75
-353.86
Net Investments
-250.75
-22.40
-42.83
-260.57
-0.01
-6.57
-1.22
-24.40
-7.01
-18.65
Others
-283.48
-406.25
154.05
-107.58
15.13
8.53
11.50
89.88
-228.44
-24.44
Cash from Financing Activity
249.83
-26.64
30.26
254.70
-127.66
-44.77
42.24
-53.61
103.32
486.08
Net Cash Inflow / Outflow
93.10
-28.80
27.02
46.71
-1.37
0.02
0.59
-10.30
-26.91
24.42
Opening Cash & Equivalents
45.67
75.35
48.46
1.69
2.97
3.00
2.42
12.81
39.53
15.11
Closing Cash & Equivalent
138.94
45.67
75.35
48.46
1.69
2.97
3.00
2.42
12.81
39.53

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
75.88
74.73
62.19
48.32
33.02
29.18
27.86
25.05
99.86
83.92
ROA
2.10%
10.89%
13.09%
20.87%
7.34%
3.00%
6.04%
8.05%
6.61%
4.31%
ROE
4.15%
21.63%
28.05%
45.15%
15.39%
6.19%
11.97%
18.12%
18.65%
14.47%
ROCE
6.64%
22.97%
25.97%
39.82%
14.14%
8.22%
13.68%
16.52%
16.35%
13.74%
Fixed Asset Turnover
0.97
1.41
1.46
1.78
1.26
1.18
1.29
1.53
1.73
1.66
Receivable days
117.42
88.66
98.37
79.52
96.76
101.97
100.40
95.66
73.56
65.47
Inventory Days
127.81
104.09
123.34
94.05
102.29
100.87
96.48
94.12
97.00
109.61
Payable days
135.42
106.10
175.76
155.37
145.69
72.80
61.13
59.14
58.52
69.29
Cash Conversion Cycle
109.81
86.64
45.95
18.21
53.36
130.03
135.75
130.64
112.05
105.79
Total Debt/Equity
0.61
0.49
0.52
0.56
0.60
0.67
0.66
0.64
1.20
1.14
Interest Cover
2.29
7.71
11.59
20.09
4.28
2.36
3.98
3.35
2.52
1.66

News Update:


  • Laurus Labs reports 30% fall in Q4 consolidated net profit
    25th Apr 2024, 16:00 PM

    Total income of the company increased by 5.47% at Rs 1,458.20 crore for Q4FY24

    Read More
  • Laurus Labs - Quarterly Results
    25th Apr 2024, 15:09 PM

    Read More
  • USFDA completes inspection at Laurus Labs’ API manufacturing facilities
    19th Apr 2024, 18:16 PM

    The inspection was successfully closed without any 483 observations

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.